The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination

Wang, Yuying; Zhou, Yujie; Zhang, Meng; Zhang, Xiaoyu; Li, Haibin; Wang, Youxin; Wang, Wei; Ji, Jian-Guang; Wu, Lijuan; Zheng, Deqiang

doi:10.1016/j.jiph.2022.12.004

Cited by 3 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concurrently, Kaur et al 11 concluded that the COVID-19 vaccines did not exhibit serious adverse reactions. In 2023, Wang et al 22 explored the prevalence of adverse reactions and demonstrated that it was similar to that of the general individuals with underlying diseases and those aged 60 years and older. These outcomes offer a scientific basis for the safety of vaccination in these populations.…”

Section: Discussionmentioning

confidence: 99%

Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

Yang,

Chen,

Cao

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The Coronavirus Disease 2019 (COVID-19) pandemic has now persisted globally for four years, resulting in a staggering death toll of over 4 million individuals. The COVID-19 vaccine has emerged as a highly effective tool in controlling the spread of this virus. However, as the number of individuals receiving COVID-19. In this context, the investigation of adverse reactions related to COVID-19 vaccines holds paramount importance in relevant research. The purpose is to evaluate the current research status regarding adverse reactions associated with COVID-19 vaccines, offering insights for future research. A total of 3,746 articles were included in this analysis, and there has been a notable upward trajectory in the volume of published articles. The CiteSpace v6.1.R6, VOSviewer, SCImago Graphica, and Excel 2019 were employed to analyze and visualize the results. The institutions, countries, journals, authors, co-cited references, and keywords of these articles were analyzed. Furthermore, this study delves into the characteristics of articles on adverse reactions associated with COVID-19 vaccines. It was observed that the number of studies on COVID-19 vaccines has increased year by year since 2019 and witnessed a surge in output in 2021. The vast majority of studies have affirmed the overall safety of COVID-19 vaccines, with adverse reactions tending to be more concentrated in specific diseases. These findings provide valuable ideas for future research in this field and suggest the importance of strengthening international cooperation on adverse reactions to COVID-19 vaccines.

show abstract

Section: Discussionmentioning

confidence: 99%

Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

Yang,

Chen,

Cao

et al. 2023

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Impact of Comorbidities and Skin Diseases on Post-Vaccination Reactions: A Study on COVID-19 Vaccinations in Poland

Jęśkowiak-Kossakowska,

Nowotarska,

Grosman-Dziewiszek

et al. 2024

JCM

View full text Add to dashboard Cite

Background: The COVID-19 pandemic necessitated rapid and widespread vaccination efforts, which proved critical in reducing the severity and mortality of the virus. However, the interplay between vaccinations, pre-existing skin conditions, and other comorbidities still needs to be explored. This study investigated the occurrence and severity of adverse events following immunization (AEFIs) with COVID-19 vaccines in individuals with chronic skin diseases and comorbidities within a Central European cohort. Methods: An anonymous online survey was conducted between May 2022 and February 2023, targeting students and employees of universities in Wrocław, Poland. A total of 513 respondents were analyzed, focusing on AEFIs following the first, second, and third doses of COVID-19 vaccines and the effects of COVID-19 on conditions such as atopic dermatitis, psoriasis, vitiligo, acne vulgaris, rosacea, and various comorbidities. Results: COVID-19 vaccination effectively protected against severe disease across all doses. The analysis revealed no significant impact of either COVID-19 infection or vaccination on the course of selected skin diseases and comorbidities. The reporting of AEFIs to the Sanitary Inspection was notably low. The Moderna and Pfizer mRNA-based vaccines were associated with a higher reported number of AEFIs, particularly after the second and third doses, compared to AstraZeneca, which exhibited fewer adverse events after subsequent doses. Conclusions: COVID-19 vaccination is both safe and effective, even in patients with pre-existing skin conditions and comorbidities. Vaccine selection may benefit from considering individual health profiles, and better reporting of AEFIs is needed to enhance vaccine safety monitoring.

show abstract

Análisis descriptivo de los brotes de COVID-19 ocurridos en las instituciones de protección integral a la persona mayor con servicios de larga estancia durante el año 2021 en la ciudad de Bogotá

Peña Mosquera,

Hernández Camelo

2023

bed

View full text Add to dashboard Cite

Este estudio descriptivo, de tipo transversal, tuvo como objetivo caracterizar el comportamiento de los brotes de COVID-19 ocurridos en las instituciones para la protección integral del adulto mayor IPIPM de Bogotá, durante las semanas epidemiológicas de la 1 a la 53 de 2021. Se llevó a cabo mediante el análisis de la base nominal de casos que fue suministrada por el Subsistema de Urgencias y Emergencias de la Secretaria Distrital de Salud, definiendo por localidad durante el año 2021, la caracterización sociodemográfica de los individuos involucrados, la proporción de personas hospitalizadas y fallecidas, y la prevalencia de los síntomas presentados. Durante el 2021 se presentaron un total de 4127 casos asociados a brotes en 168 instituciones de larga estancia, siendo la localidad Tunjuelito la que presentó mayor número de casos (n=259) en la única institución presente allí; por otra parte, la mayoría casos corresponde a mujeres mayores de 60 años sin pertenencia a un grupo étnico, afiliadas al régimen contributivo. En cuanto a los fallecimientos, se calculó que para el año 2021 el 2,4 % (n=98) del total de los casos de COVID-19 reportados y el 5,9 % para los casos con prueba PCR positiva (n=76) terminó en fallecimiento del individuo, es decir en el 2021 murieron 193 personas menos que en el 2020. Las jornadas de vacunación implementadas por la Secretaría Distrital de Salud en las IPIPM, así como la pronta respuesta por parte de los establecimientos en la atención de dichos casos, marcaron probablemente una diferencia en la severidad de las consecuencias de los brotes presentados en el año 2021.

show abstract

The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination

Cited by 3 publications

References 34 publications

Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

Impact of Comorbidities and Skin Diseases on Post-Vaccination Reactions: A Study on COVID-19 Vaccinations in Poland

Análisis descriptivo de los brotes de COVID-19 ocurridos en las instituciones de protección integral a la persona mayor con servicios de larga estancia durante el año 2021 en la ciudad de Bogotá

Contact Info

Product

Resources

About